BR9606412A - Vírus recombinante da herpes com promotor de gene gb - Google Patents

Vírus recombinante da herpes com promotor de gene gb

Info

Publication number
BR9606412A
BR9606412A BR9606412A BR9606412A BR9606412A BR 9606412 A BR9606412 A BR 9606412A BR 9606412 A BR9606412 A BR 9606412A BR 9606412 A BR9606412 A BR 9606412A BR 9606412 A BR9606412 A BR 9606412A
Authority
BR
Brazil
Prior art keywords
gene
alien
gene promoter
herpes virus
recombinant herpes
Prior art date
Application number
BR9606412A
Other languages
English (en)
Inventor
Kengo Sonoda
Masashi Sakaguchi
Kazuo Matsuo
Fukusaburo Hamada
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Publication of BR9606412A publication Critical patent/BR9606412A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
BR9606412A 1995-06-02 1996-05-28 Vírus recombinante da herpes com promotor de gene gb BR9606412A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7160106A JPH08322559A (ja) 1995-06-02 1995-06-02 ｇＢ遺伝子プロモーターを用いた組換えヘルペスウイルス
PCT/JP1996/001428 WO1996038565A1 (fr) 1995-06-02 1996-05-28 HERPESVIRUS RECOMBINE ET UTILISATION D'UN PROMOTEUR DE GENE gB

Publications (1)

Publication Number Publication Date
BR9606412A true BR9606412A (pt) 1997-09-30

Family

ID=15707989

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606412A BR9606412A (pt) 1995-06-02 1996-05-28 Vírus recombinante da herpes com promotor de gene gb

Country Status (11)

Country Link
US (1) US6013261A (pt)
EP (1) EP0774513B1 (pt)
JP (2) JPH08322559A (pt)
CN (1) CN1155710C (pt)
AT (1) ATE236254T1 (pt)
AU (1) AU692395B2 (pt)
BR (1) BR9606412A (pt)
CA (1) CA2196416C (pt)
DE (1) DE69627109T2 (pt)
ES (1) ES2196148T3 (pt)
WO (1) WO1996038565A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
HUP9802974A1 (hu) * 1998-12-19 2000-09-28 Mezőgazdasági Biotechnológiai Kutatóközpont Fertőző bursitis elleni DNS-vakcina
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
CN100510082C (zh) * 2007-06-18 2009-07-08 扬州大学 一种淋巴组织特异性基因表达调控序列
CN103235127A (zh) * 2013-04-17 2013-08-07 河南省农业科学院 马立克氏病病毒快速检测试纸条
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
AU2014362234B2 (en) * 2013-12-11 2019-09-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Human herpesvirus trimeric glycoprotein B, protein complexes comprising trimeric gB and their use as vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2583115B2 (ja) * 1988-09-10 1997-02-19 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
JP3339854B2 (ja) * 1988-09-13 2002-10-28 メリアル ウイルスワクチン
US5558860A (en) * 1988-09-13 1996-09-24 Rhone Merieux Viral vaccines
JP3428666B2 (ja) * 1991-07-09 2003-07-22 財団法人化学及血清療法研究所 組換えマレック病ウイルスおよびその製法
US5659153A (en) * 1995-03-03 1997-08-19 International Business Machines Corporation Thermoformed three dimensional wiring module

Also Published As

Publication number Publication date
WO1996038565A1 (fr) 1996-12-05
ES2196148T3 (es) 2003-12-16
US6013261A (en) 2000-01-11
MX9700870A (es) 1997-09-30
CA2196416A1 (en) 1996-12-05
ATE236254T1 (de) 2003-04-15
EP0774513A1 (en) 1997-05-21
CN1155710C (zh) 2004-06-30
DE69627109D1 (de) 2003-05-08
DE69627109T2 (de) 2003-12-18
CA2196416C (en) 2011-03-08
EP0774513A4 (en) 1999-10-13
EP0774513B1 (en) 2003-04-02
CN1159209A (zh) 1997-09-10
JP3933689B2 (ja) 2007-06-20
AU5780796A (en) 1996-12-18
AU692395B2 (en) 1998-06-04
JPH08322559A (ja) 1996-12-10

Similar Documents

Publication Publication Date Title
AU625328B2 (en) Recombinant varicella-zoster glycoproteins and their derivatives
CA2068320A1 (en) Production of recombinant human interleukin-1 inhibitor
AU1628895A (en) Recombinant virus
ATE313270T1 (de) Verwendung von hoch-verestertem pektin in sauren, proteinhaltigen nahrungsmitteln
AU2853395A (en) Recombinant vectors derived from adenovirus for use in gene therapy
DE68922932D1 (de) Hohe Expression von Proteinen in Hefe.
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
ATE195347T1 (de) Methoden der erhöhung der sekretion von überexpremierten proteinen
AU1632392A (en) Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus
DE3587991D1 (de) Rekombinanter herpes simplex gb-gd impfstoff.
AU5421594A (en) Recombinant method and host for manufacture of xylitol
PT1021553E (pt) Cassette de expressao eucariotica de genes e suas utilizacoes
BR9606412A (pt) Vírus recombinante da herpes com promotor de gene gb
AU1257092A (en) Interferon sensitive recombinant poxvirus vaccine
AU6282896A (en) Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
PT599971E (pt) Promotor de levedura e sua utilizacao
NO964874L (no) Fusjonsglykoprotein fra HCMV og HSV
CA2002862A1 (en) Cloning and expression of a protein which modulates cellular response to type i interferon
EP0623172A4 (en) RECOMBINANT POXVIRUS AS A VACCINE AGAINST THE VIRUS OF MAREK DISEASE.
DE69332480D1 (de) Impfstoff-vektoren von rekombinantem katzen-herpesvirus
ES2160605T3 (es) Aminopeptidasa novedosa a partir de streptomyces.
ES2113322A1 (es) Virus mixomatoso recombinante.
AU1948788A (en) Expression of immunologically active proteins of human b-lymphotropic virus
AU2521888A (en) Recombinant dna constructs containing an r3 promoter
DK177591D0 (da) Rekombinant humicola lipase

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law